Recombinant Rat ARHGAP17 Protein, His (Fc)-Avi-tagged
Cat.No. : | ARHGAP17-419R |
Product Overview : | Recombinant Rat ARHGAP17 with His (Fc)-Avi tag was expressed and purified |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Rat |
Tag : | His&Fc&Avi |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method |
Purity : | ≥85% by SDS-PAGE |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Storage Buffer : | PBS buffer |
Gene Name : | Arhgap17 Rho GTPase activating protein 17 [ Rattus norvegicus ] |
Official Symbol : | ARHGAP17 |
Gene ID : | 63994 |
mRNA Refseq : | NM_022244.2 |
Protein Refseq : | NP_071580.1 |
UniProt ID : | Q99N37 |
Products Types
◆ Recombinant Protein | ||
Arhgap17-1680M | Recombinant Mouse Arhgap17 Protein, Myc/DDK-tagged | +Inquiry |
Arhgap17-245M | Recombinant Mouse Arhgap17 Protein, His-tagged | +Inquiry |
ARHGAP17-763R | Recombinant Rat ARHGAP17 Protein | +Inquiry |
ARHGAP17-763H | Recombinant Human ARHGAP17 protein, GST-tagged | +Inquiry |
◆ Lysates | ||
ARHGAP17-8743HCL | Recombinant Human ARHGAP17 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (8)
Write a reviewThey may offer educational resources such as technical guides, protocols, and application notes, which can aid researchers in understanding the principles, techniques, and potential applications of ARHGAP17 protein in their studies.
These resources can enhance the efficiency and accuracy of experimental workflows and contribute to successful outcomes.
Their collaboration, expertise, and customized solutions contribute to the successful execution of experiments, reliable data generation, and the advancement of scientific knowledge in the field.
the manufacturer's support is crucial for researchers using ARHGAP17 protein in trials.
Its unwavering stability and functionality have significantly contributed to the success and validity of my experimental outcomes.
Trusting in its consistent results, I am able to embark on my research with assurance and optimism.
the ARHGAP17 protein stands out for its exceptional quality, coupled with the outstanding technical support delivered by the manufacturer.
I enthusiastically recommend the ARHGAP17 protein to fellow researchers who seek an unparalleled product accompanied by dedicated customer assistance.
Q&As (6)
Ask a questionThere is limited information on ARHGAP17 polymorphisms associated with phenotypic variations in humans. The genetic variations or single nucleotide polymorphisms (SNPs) within ARHGAP17 and their association with specific traits, diseases, or phenotypic variations have not been well-investigated. Further studies are necessary to understand the impact of ARHGAP17 polymorphisms on human phenotypes.
While there is limited research on the specific role of ARHGAP17 in cancer, dysregulation of Rho GTPases and other GAP proteins has been implicated in cancer progression. Since ARHGAP17 negatively regulates RhoA, alterations in its expression or function may impact tumor cell behavior, invasion, and metastasis. Further studies are needed to explore the potential involvement of ARHGAP17 in cancer.
The specific functional or regulatory interactions between ARHGAP17 and other GAP proteins have not been extensively studied. However, as ARHGAP17 belongs to the GAP family, there could be potential interactions with other GAP proteins that regulate Rho GTPases. Further research is needed to explore these possible interactions.
Currently, there are no known drugs or compounds specifically targeted towards ARHGAP17. However, since ARHGAP17 regulates RhoA signaling, drugs targeted at RhoA or other downstream effectors may indirectly affect ARHGAP17 function. Therapeutic strategies that modulate RhoA activity could potentially impact ARHGAP17-mediated processes.
Due to the limited understanding of ARHGAP17's function and its direct involvement in specific diseases, it is not currently considered a well-established therapeutic target. However, further research may uncover specific contexts where modulating ARHGAP17 activity could be beneficial, particularly in diseases related to abnormal Rho GTPase signaling.
Limited research has been conducted on the association of ARHGAP17 with human diseases. However, altered expression or mutations in Rho GTPases or other GAP proteins have been implicated in several diseases, including cancer, neurological disorders, and cardiovascular diseases. More studies are needed to determine if ARHGAP17 alterations contribute to disease development.
Ask a Question for All ARHGAP17 Products
Required fields are marked with *
My Review for All ARHGAP17 Products
Required fields are marked with *
Inquiry Basket